A detailed history of Rs Crum Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Rs Crum Inc. holds 2,180 shares of ABBV stock, worth $371,363. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,180
Previous 2,181 0.05%
Holding current value
$371,363
Previous $374,000 14.97%
% of portfolio
0.11%
Previous 0.1%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $163 - $199
-1 Reduced 0.05%
2,180 $430,000
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $74,299 - $86,764
480 Added 28.22%
2,181 $374,000
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $18,539 - $21,123
-116 Reduced 6.38%
1,701 $309,000
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $4,540 - $5,114
-33 Reduced 1.78%
1,817 $281,000
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $33,397 - $38,662
250 Added 15.63%
1,850 $275,000
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $215,138 - $246,749
-1,603 Reduced 50.05%
1,600 $215,000
Q4 2021

Feb 22, 2022

BUY
$107.43 - $135.93 $344,098 - $435,383
3,203 New
3,203 $434,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Rs Crum Inc. Portfolio

Follow Rs Crum Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rs Crum Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rs Crum Inc. with notifications on news.